Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1994 1
1995 2
1998 4
2001 2
2002 4
2003 3
2004 1
2005 3
2006 3
2007 8
2008 7
2009 4
2010 11
2011 11
2012 8
2013 7
2014 17
2015 12
2016 10
2017 10
2018 10
2019 18
2020 12
2021 17
2022 15
2023 14
2024 10
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension.
Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K; Study Group. Ogo T, et al. Among authors: sakao s. Eur Respir J. 2022 Jul 7;60(1):2101694. doi: 10.1183/13993003.01694-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34824052 Free PMC article. Clinical Trial.
Lung imaging in COPD and asthma.
Tanabe N, Nakagawa H, Sakao S, Ohno Y, Shimizu K, Nakamura H, Hanaoka M, Nakano Y, Hirai T. Tanabe N, et al. Among authors: sakao s. Respir Investig. 2024 Nov;62(6):995-1005. doi: 10.1016/j.resinv.2024.08.014. Epub 2024 Aug 29. Respir Investig. 2024. PMID: 39213987 Free article. Review.
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients.
Aoki A, Iwamura C, Kiuchi M, Tsuji K, Sasaki A, Hishiya T, Hirasawa R, Kokubo K, Kuriyama S, Onodera A, Shimada T, Nagaoka T, Ishikawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Nakamura S, Urushibara T, Kaneda S, Sakao S, Nishida O, Takahashi K, Kimura MY, Motohashi S, Igari H, Ikehara Y, Nakajima H, Suzuki T, Hanaoka H, Nakada TA, Kikuchi T, Nakayama T, Yokote K, Hirahara K. Aoki A, et al. Among authors: sakao s. J Clin Immunol. 2024 Apr 22;44(4):104. doi: 10.1007/s10875-024-01708-7. J Clin Immunol. 2024. PMID: 38647550 Free PMC article.
Dynamic chest radiographic evaluation of the effects of tiotropium/olodaterol combination therapy in chronic obstructive pulmonary disease: the EMBODY study protocol for an open-label, prospective, single-centre, non-controlled, comparative study.
Ikari J, Katsumata M, Urano A, Imamoto T, Suzuki Y, Nishiyama A, Yokota H, Ono K, Okamoto K, Abe E, Kamata T, Fujii S, Okumura K, Ota J, Suzuki E, Kawata N, Ozawa Y, Masuda Y, Matsushita K, Sakao S, Uno T, Tatsumi K, Suzuki T. Ikari J, et al. Among authors: sakao s. BMJ Open Respir Res. 2024 Aug 5;11(1):e002374. doi: 10.1136/bmjresp-2024-002374. BMJ Open Respir Res. 2024. PMID: 39107000 Free PMC article.
Reply to letter to Editor.
Yamamoto K, Nishimura R, Kato F, Naito A, Suda R, Sekine A, Jujo T, Shigeta A, Sakao S, Tanabe N, Tatsumi K. Yamamoto K, et al. Among authors: sakao s. Int J Cardiol. 2020 May 15;307:164. doi: 10.1016/j.ijcard.2020.03.015. Int J Cardiol. 2020. PMID: 32354405 No abstract available.
202 results